Clinical Trials Directory

Trials / Completed

CompletedNCT06665503

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Hormozgan University of Medical Sciences · Academic / Other
Sex
All
Age
3 Months – 3 Years
Healthy volunteers
Accepted

Summary

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

Detailed description

The participants will be children aged 3 months to 3 years.The zinc group received oral zinc supplementation; 2.5 ml every 12 hours for children aged \<1 year and 5 ml every 12 hours for older children; the probiotics group received oral probiotics; 1 probiotic sachet; and the control group received nothing.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTZinc Supplement, probioticreceived oral zinc supplementation; 2.5 ml every 12 hours for children aged \<1 year and 5 ml every 12 hours for older children; the probiotics group received oral probiotics; 1 probiotic sachet

Timeline

Start date
2020-09-01
Primary completion
2021-03-01
Completion
2021-05-01
First posted
2024-10-30
Last updated
2024-11-12

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT06665503. Inclusion in this directory is not an endorsement.

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran (NCT06665503) · Clinical Trials Directory